200 related articles for article (PubMed ID: 17584165)
1. Expression, purification, and antibody binding activity of human papillomavirus 16 L1 protein fused to maltose binding protein.
Cho HJ; Hahm MS; Kim MK; Han IK; Jung WW; Choi HG; Kim JA; Oh YK
Protein Pept Lett; 2007; 14(5):417-24. PubMed ID: 17584165
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
[TBL] [Abstract][Full Text] [Related]
3. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.
Hassan SW; Waheed MT; Müller M; Clarke JL; Shinwari ZK; Lössl AG
Hum Vaccin Immunother; 2014; 10(10):2975-82. PubMed ID: 25483463
[TBL] [Abstract][Full Text] [Related]
4. Two-step chromatographic purification of glutathione S-transferase-tagged human papillomavirus type 16 E6 protein and its application for serology.
Xu ML; Kim SC; Kim HJ; Ju W; Kim YH; Kim HJ
Protein Expr Purif; 2017 Apr; 132():19-26. PubMed ID: 28089881
[TBL] [Abstract][Full Text] [Related]
5. Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1alpha from Escherichia coli.
Cho HJ; Lee Y; Chang RS; Hahm MS; Kim MK; Kim YB; Oh YK
Protein Expr Purif; 2008 Jul; 60(1):37-45. PubMed ID: 18455434
[TBL] [Abstract][Full Text] [Related]
6. Optimized production strategy of the major capsid protein HPV 16L1 non-assembly variant in E. coli.
Roos N; Breiner B; Preuss L; Lilie H; Hipp K; Herrmann H; Horn T; Biener R; Iftner T; Simon C
Protein Expr Purif; 2020 Nov; 175():105690. PubMed ID: 32681956
[TBL] [Abstract][Full Text] [Related]
7. Solubility of proteins isolated from inclusion bodies is enhanced by fusion to maltose-binding protein or thioredoxin.
Sachdev D; Chirgwin JM
Protein Expr Purif; 1998 Feb; 12(1):122-32. PubMed ID: 9473466
[TBL] [Abstract][Full Text] [Related]
8. [Prokaryotic expression of HPV 16 L1 gene and identification of its immune activity].
Hao DF; Ma ZH; Wang YP; Rexidan ; Zhang FC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):428-31. PubMed ID: 15989783
[TBL] [Abstract][Full Text] [Related]
9. Expression and Purification of Recombinant Proteins in Escherichia coli with a His
Raran-Kurussi S; Waugh DS
Methods Mol Biol; 2017; 1607():1-15. PubMed ID: 28573567
[TBL] [Abstract][Full Text] [Related]
10. Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model.
López-Toledo G; Schädlich L; Alonso-Castro ÁJ; Monroy-García A; García-Rocha R; Guido MC; Gissmann L; García-Carrancá A
Viral Immunol; 2016 Jun; 29(5):276-87. PubMed ID: 27058179
[TBL] [Abstract][Full Text] [Related]
11. [Production of human papillomavirus type 16 virus-like particles and its immunogenicity].
Wei MX; Li SW; Huang B; Shen WT; Su YZ; Zhang CH; Gu Y; Du HL; Zhang J; Xia NS
Bing Du Xue Bao; 2009 Jul; 25(4):245-50. PubMed ID: 19769155
[TBL] [Abstract][Full Text] [Related]
12. [Expression and purification of human papillomavirus type16 L1 protein in a prokaryotic expression system].
Bao G; Gu H; Lin D; Zhuang M; Shui L; Wang J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):280-3. PubMed ID: 12224300
[TBL] [Abstract][Full Text] [Related]
13. High-Level Production of Human Papillomavirus (HPV) Type 16 L1 in Escherichia coli.
Bang HB; Lee YH; Lee YJ; Jeong KJ
J Microbiol Biotechnol; 2016 Feb; 26(2):356-63. PubMed ID: 26608168
[TBL] [Abstract][Full Text] [Related]
14. Expression and purification of soluble human cystatin C in Escherichia coli with maltose-binding protein as a soluble partner.
Zhang Q; Zhao X; Xu X; Tang B; Zha Z; Zhang M; Yao D; Chen X; Wu X; Cao L; Guo H
Protein Expr Purif; 2014 Dec; 104():14-9. PubMed ID: 25260712
[TBL] [Abstract][Full Text] [Related]
15. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused.
Kapust RB; Waugh DS
Protein Sci; 1999 Aug; 8(8):1668-74. PubMed ID: 10452611
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of soluble human papillomavirus L1 through coexpression of molecular chaperonin in Escherichia coli.
Pan D; Zha X; Yu X; Wu Y
Protein Expr Purif; 2016 Apr; 120():92-8. PubMed ID: 26732286
[TBL] [Abstract][Full Text] [Related]
17. Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae.
Park MA; Kim HJ; Kim HJ
Protein Expr Purif; 2008 May; 59(1):175-81. PubMed ID: 18343683
[TBL] [Abstract][Full Text] [Related]
18. [Preparation and identification of type specific and conformation dependent HPV16 L1 protein monoclonal antibody.].
Yan XF; Xu Y; Zheng J; Lai BC; Wang YL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Dec; 25(12):1133-5. PubMed ID: 19961800
[TBL] [Abstract][Full Text] [Related]
19. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].
Tian HW; Ye ZM; Lu ZH; Jao R; Bian T; Zhao L; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):33-7. PubMed ID: 16816859
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of soluble protein in Escherichia coli using a His6-tag and maltose-binding-protein double-affinity fusion system.
Pryor KD; Leiting B
Protein Expr Purif; 1997 Aug; 10(3):309-19. PubMed ID: 9268677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
